Bollard Catherine 4

What Happened
Director Catherine Bollard reported an open-market purchase of 4,405 shares of Cabaletta Bio, Inc. (CABA) on 2026-01-21 at a reported price of $2.27 per share, for a total reported cost of about $9,982. This was a purchase (Form 4 code P), which is generally viewed as a direct acquisition rather than a sale.

Key Details

• Transaction date: 2026-01-21
• Price: $2.27 per share; reported total = $9,982
• Shares acquired: 4,405 (open-market purchase)
• Shares owned after transaction: Not specified in the provided filing details
• Filing timeliness: Report filed with the SEC on 2026-01-21 (no late filing indicated)
• No footnotes or 10b5-1 plan, tax withholding, or derivative activity noted in the supplied details

Context
Purchases by directors can signal personal confidence, but this is a relatively small-dollar insider buy (~$10k) and should be weighed accordingly. Retail investors should combine this information with company fundamentals, recent news, and broader insider activity before drawing conclusions.